CVS HEALTH CORPORATION (CVS) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 415.09B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 230.41B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $415.09B | $230.41B | (m) |
| 2026-03-31 | (m) | $407.90B | $225.55B | (m) |
| 2025-12-31 | (m) | $402.07B | $221.17B | (m) |
| 2025-09-30 | (m) | $394.08B | $217.38B | (m) |
| 2025-06-30 | (m) | $386.64B | $213.28B | (m) |
| 2025-03-31 | (m) | $378.96B | $209.27B | (m) |
| 2024-12-31 | (m) | $372.81B | $206.29B | (m) |
| 2024-09-30 | (m) | $368.91B | $208.44B | (m) |
| 2024-06-30 | (m) | $363.25B | $210.18B | (m) |
| 2024-03-31 | (m) | $360.94B | $213.72B | (m) |
| 2023-12-31 | (m) | $357.78B | $217.10B | (m) |
| 2023-09-30 | (m) | $347.81B | $211.41B | (m) |
| 2023-06-30 | (m) | $339.20B | $207.08B | (m) |
| 2023-03-31 | (m) | $330.92B | $202.84B | (m) |
| 2022-12-31 | (m) | $322.47B | $196.89B | (m) |
| 2022-09-30 | (m) | $315.23B | $191.54B | (m) |
| 2022-06-30 | (m) | $307.86B | $186.19B | (m) |
| 2022-03-31 | (m) | $299.84B | $180.42B | (m) |
| 2021-12-31 | (m) | $292.11B | $175.80B | (m) |
| 2021-09-30 | (m) | $285.06B | $171.88B | (m) |
| 2021-06-30 | (m) | $278.32B | $167.81B | (m) |
| 2021-03-31 | (m) | $271.05B | $164.53B | (m) |
| 2020-12-31 | (m) | $268.71B | $163.98B | (m) |
| 2020-09-30 | (m) | $266.85B | $163.59B | (m) |
| 2020-06-30 | (m) | $264.34B | $163.09B | (m) |
| 2020-03-31 | (m) | $262.13B | $161.82B | (m) |
| 2019-12-31 | (m) | $256.78B | $158.72B | (m) |
| 2019-09-30 | (m) | $243.33B | $157.22B | (m) |
| 2019-06-30 | (m) | $226.05B | $156.28B | (m) |
| 2019-03-31 | (m) | $209.62B | $156.19B | (m) |
| 2018-12-31 | (m) | $193.92B | $156.45B | (m) |
| 2018-09-30 | $29.32B | $188.06B | (m) | 15.59% |
| 2018-06-30 | $29.11B | $186.97B | (m) | 15.57% |
| 2018-03-31 | $28.83B | $185.94B | (m) | 15.51% |
| 2017-12-31 | $28.55B | $184.76B | (m) | 15.45% |
| 2017-09-30 | $28.25B | $182.35B | (m) | 15.49% |
| 2017-06-30 | $28.61B | $180.78B | (m) | 15.83% |
| 2017-03-31 | $28.69B | $178.82B | (m) | 16.05% |
| 2016-12-31 | $28.86B | $177.53B | (m) | 16.26% |
| 2016-09-30 | $28.55B | $172.70B | (m) | 16.53% |
| 2016-06-30 | $27.72B | $166.73B | (m) | 16.63% |
| 2016-03-31 | $27.11B | $160.17B | (m) | 16.92% |
| 2015-12-31 | $26.53B | $153.29B | (m) | 17.31% |
| 2015-09-30 | $25.86B | $149.20B | (m) | 17.33% |
| 2015-06-30 | $25.67B | $145.58B | (m) | 17.63% |
| 2015-03-31 | $25.59B | $143.01B | (m) | 17.89% |
| 2014-12-31 | $25.37B | $139.37B | (m) | 18.20% |
| 2014-09-30 | $25.07B | $135.14B | (m) | 18.55% |
| 2014-06-30 | $24.63B | $132.05B | (m) | 18.65% |
| 2014-03-31 | $24.15B | $128.70B | (m) | 18.76% |
| 2013-12-31 | $23.78B | $126.76B | (m) | 18.76% |
| 2013-09-30 | $23.75B | $125.37B | (m) | 18.94% |
| 2013-06-30 | $23.36B | $123.63B | (m) | 18.90% |
| 2013-03-31 | $22.98B | $123.10B | (m) | 18.66% |
| 2012-12-31 | $22.51B | $123.13B | (m) | 18.28% |
| 2012-09-30 | $21.76B | $120.06B | (m) | 18.13% |
| 2012-06-30 | $21.30B | $116.50B | (m) | 18.28% |
| 2012-03-31 | $20.93B | $112.20B | (m) | 18.66% |
| 2011-12-31 | $20.56B | $107.10B | (m) | 19.20% |
| 2011-09-30 | $20.50B | $104.01B | (m) | 19.71% |
| 2011-06-30 | $20.34B | $101.16B | (m) | 20.10% |
| 2011-03-31 | $20.26B | $98.53B | (m) | 20.56% |
| 2010-12-31 | $20.26B | $96.41B | (m) | 21.01% |
| 2010-09-30 | $20.36B | $97.46B | (m) | 20.89% |
| 2010-06-30 | $20.35B | $98.23B | (m) | 20.71% |
| 2010-03-31 | $20.38B | $99.09B | (m) | 20.56% |
| 2009-12-31 | $20.38B | $98.73B | (m) | 20.64% |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | $18.29B | $87.47B | (m) | 20.91% |
| 2008-09-27 | (m) | (m) | (m) | (m) |
| 2008-06-28 | (m) | (m) | (m) | (m) |
| 2007-12-29 | $16.11B | $76.33B | (m) | 21.10% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |